Skip to Content

Join the 'Juvenile Idiopathic Arthritis' group to help and get support from people like you.

Juvenile Idiopathic Arthritis News

FDA Approves Hyrimoz (adalimumab-adaz), a Biosimilar to Humira

Posted 1 Nov 2018 by Drugs.com

Holzkirchen, Germany, October 31, 2018 - Sandoz, a Novartis division and the pioneer and global leader in biosimilars, today announced that the US Food and Drug Administration (FDA) approved its biosimilar, Hyrimoz (adalimumab-adaz). The FDA granted approval for the treatment of rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA) in patients four years of age and older, psoriatic ...

Exercising With Rheumatoid Arthritis

Posted 20 Sep 2018 by Drugs.com

THURSDAY, Sept. 20, 2018 – Different from osteoarthritis, which is the wear-and-tear breakdown of joint cartilage experienced over time, rheumatoid arthritis, or RA, is an autoimmune disease that causes both pain and intense fatigue. When you're in the throes of a flare, exercise may seem like mission impossible and you might be advised to rest until it passes. But exercise is an essential part ...

FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA)

Posted 16 Sep 2018 by Drugs.com

South San Francisco, CA – September 13, 2018 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved the subcutaneous (SC) formulation of Actemra (tocilizumab) for the treatment of active systemic juvenile idiopathic arthritis (SJIA) in patients two years of age and older. Actemra can be given alone or ...

FDA Approves Subcutaneous Formulation of Actemra for use in Active Polyarticular Juvenile Idiopathic Arthritis

Posted 16 May 2018 by Drugs.com

South San Francisco, CA – May 14, 2018 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved the subcutaneous (SC) formulation of Actemra® (tocilizumab) for the treatment of active polyarticular juvenile idiopathic arthritis (PJIA) in patients two years of age and older. Actemra can be given alone or ...

Menopause May Worsen Rheumatoid Arthritis Symptoms

Posted 5 Feb 2018 by Drugs.com

MONDAY, Feb. 5, 2018 – Menopause may speed physical decline in women with rheumatoid arthritis (RA), a new study suggests. While rheumatoid arthritis rates in women are three times higher than in men, and women with RA have more severe physical decline and disability, sex-based differences in RA are poorly understood, the researchers said. Rheumatoid arthritis is an autoimmune disorder that ...

FDA Approves Cyltezo (adalimumab-adbm), a Biosimilar to Humira

Posted 30 Aug 2017 by Drugs.com

Ridgefield, Conn., August 29, 2017 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Cyltezo, a biosimilar to Humira, in a pre-filled syringe for the treatment of multiple chronic inflammatory diseases, including: moderate to severe active rheumatoid arthritis moderate to severe polyarticular juvenile idiopathic arthritis** a ...

Certain Jobs Linked to Raised Risk of Rheumatoid Arthritis

Posted 10 Aug 2017 by Drugs.com

THURSDAY, Aug. 10, 2017 – Rheumatoid arthritis, a painful disease in which a person's immune system attacks the joints, appears to be more common among people in certain types of jobs, researchers suggest. The findings "indicate that work-related factors, such as airborne harmful exposures, may contribute to disease development," study author Anna Ilar said. She is a doctoral student in ...

Fish Eaters Report Less Rheumatoid Arthritis Pain

Posted 23 Jun 2017 by Drugs.com

FRIDAY, June 23, 2017 – Eating fish at least twice a week may significantly reduce the pain and swelling associated with rheumatoid arthritis, a new study says. Prior studies have shown a beneficial effect of fish oil supplements on rheumatoid arthritis symptoms, but less is known about the value of eating fish containing omega-3, the researchers said. "We wanted to investigate whether eating ...

FDA Approves Xatmep (methotrexate) Oral Solution

Posted 27 Apr 2017 by Drugs.com

Denver, April 26, 2017 — Silvergate Pharmaceuticals, Inc. leaders in the development and commercialization of innovative and safe medicines for children, today announced that the United States Food and Drug Administration (FDA) approved Xatmep (methotrexate) Oral Solution, the first and only FDA-approved methotrexate oral solution. Xatmep is indicated for the treatment of acute lymphoblastic l ...

Early Treatment Equals Better Results for Rheumatoid Arthritis

Posted 25 Apr 2017 by Drugs.com

TUESDAY, April 25, 2017 – Treating rheumatoid arthritis early may make for better outcomes, a new study suggests. Patients who were treated within six months of developing the first signs of the autoimmune disease did better in the long run and were less likely to suffer early death, British researchers found. The findings stem from an analysis of more than 600 patients who were initially ...

1 in 4 U.S. Adults Disabled by Arthritis: CDC

Posted 8 Mar 2017 by Drugs.com

TUESDAY, March 7, 2017 – Arthritis is expanding its grip on Americans, with 24 million adults limited in their everyday activities because of the debilitating joint disease, U.S. health officials say. Overall, 54 million adults – or one in four – report an arthritis diagnosis. And the number of people disabled by it has jumped 20 percent since 2002, the U.S. Centers for Disease Control and ...

Even a Little Exercise Can Help With Arthritis, Study Says

Posted 31 Jan 2017 by Drugs.com

TUESDAY, Jan. 31, 2017 – Just a little physical activity seems to go a long way toward helping older adults with arthritis remain able to do daily tasks, a new study finds. Older adults with arthritis-related joint pain and stiffness need to keep moving to remain functionally independent. But only 10 percent of older Americans with arthritis in their knees meet federal guidelines of at least 150 ...

Health Tip: What's Behind My Foot Arthritis?

Posted 21 Dec 2016 by Drugs.com

-- The stiffness and pain that accompany arthritis are particularly noticable when they affect the feet. Here are possible reasons behind foot arthritis, courtesy of the American Podiatric Medical Association: Foot injuries, particularly if they were not treated properly. Viral or bacterial infections that affect the joints. Inflammatory bowel disease. Prescribed medications or use of illegal ...

Health Tip: Exercising With Arthritis

Posted 1 Dec 2016 by Drugs.com

-- Exercise usually is good for those with arthritis, but there are many potential obstacles to keep you inactive. Here are strategies to keep you moving, courtesy of the Arthritis Foundation: No time? Exercise in short bursts, even just 10 minutes at a time. Find a fitness partner to help keep it fun. If you're having pain, try a low-impact exercise, such as swimming. Exercise even when you're ...

Moms' Rheumatoid Arthritis May Be Linked to Epilepsy Risk in Kids

Posted 16 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 16, 2016 – Some children born to mothers with rheumatoid arthritis may have higher-than-average odds of developing epilepsy, a new study suggests. Children born to mothers with rheumatoid arthritis were one-third more likely to develop epilepsy by age 4 than other children. The risk of epilepsy later in childhood was one-quarter higher for those born to moms with rheumatoid ...

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Juvenile Rheumatoid Arthritis

Related Drug Support Groups

methotrexate, Humira, Enbrel, Orencia, Actemra, infliximab, adalimumab, etanercept, Erelzi, view more... Cyltezo, Ilaris, Amjevita, Xatmep, abatacept, Rasuvo, Otrexup, tocilizumab, canakinumab, Hyrimoz